Drunken drug delivery?; Injectable formulation of schizophrenia drug approved;

> Researchers from Southern Denmark University have succeeded in developing alcohol droplets that move in water with drug delivery applications. Article

> The FDA approved a dual-chamber syringe for injection of a new formulation of the drug Abilify Maintena to treat schizophrenia, Otsuka and Lundbeck announced. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.